Literature DB >> 4014577

Oxygen consumption of middle ear and peripheral blood neutrophils in acute suppurative otitis media.

J M Bernstein, J R Humbert, M M Hliwa.   

Abstract

Using an oxygen electrode, oxygen consumption has been measured in peripheral blood neutrophils and the corresponding middle ear fluid neutrophils of 26 patients with acute suppurative otitis media. The data suggest that the middle ear fluid neutrophil is functional and is capable of producing an adequate oxygen burst in response to membrane stimulation by opsonized zymosan particles. Some middle ear neutrophils are actually capable of producing a greater respiratory burst than their counterparts in the peripheral blood. However, middle ear neutrophils do not show the increased metabolic activity at 40 degrees C, which blood neutrophils regularly displayed compared with tests performed at 37 degrees C. It is believed that this temperature (40 degrees C) is more physiological during infection and might explain why middle ear neutrophils may not always be capable of destroying bacteria, even though they are present in adequate numbers in the middle ear fluid in some cases of acute suppurative otitis media. Further studies are needed to determine the nature of the defect(s) present in middle ear neutrophil at 40 degrees C.

Entities:  

Mesh:

Year:  1985        PMID: 4014577     DOI: 10.1016/s0196-0709(85)80080-6

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  2 in total

1.  Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication.

Authors:  E Leibovitz; R Dagan; J H Laver; L Piglansky; S Raiz; M R Abboud; D M Fliss; A Leiberman; A Barzilai
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

2.  Effect of modulation of polymorphonuclear leukocyte migration with anti-CD18 antibody on pathogenesis of experimental otitis media in guinea pigs.

Authors:  J Patel; T Chonmaitree; F Schmalstieg
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.